Seven Days of Bismuth-Based Quadruple Therapy Is as Effective for the First-Line Treatment of Clarithromycin-Resistant Confirmed Helicobacter pylori Infection as 14 Days of Bismuth-Based Quadruple Therapy.
Sang-Gon MoonChul-Hyun LimHee-Jun KangArum ChoiSukil KimJung-Hwan OhPublished in: Journal of clinical medicine (2022)
infection.